Yıldırım, S. Et Al. 2022. Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?. Journal of Gastrointestinal Cancer , vol.53, no.1 , 41-44.

Yıldırım, S., ERDOĞAN, A. P., Karateke, M., Yılmaz, C., Özveren, A., Bulut, G., ... EKİNCİ, F.(2022). Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?. Journal of Gastrointestinal Cancer , vol.53, no.1, 41-44.

Yıldırım, Serkan Et Al. "Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?," Journal of Gastrointestinal Cancer , vol.53, no.1, 41-44, 2022

Yıldırım, Serkan Et Al. "Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?." Journal of Gastrointestinal Cancer , vol.53, no.1, pp.41-44, 2022

Yıldırım, S. Et Al. (2022) . "Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?." Journal of Gastrointestinal Cancer , vol.53, no.1, pp.41-44.

@article{article, author={Serkan Yıldırım Et Al. }, title={Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?}, journal={Journal of Gastrointestinal Cancer}, year=2022, pages={41-44} }